- US-listed companies
- NEUROONE MEDICAL TECHNOLOGIES Corp
- Income statement
NEUROONE MEDICAL TECHNOLOGIES CorpNMTC
Market cap
$33.4M
P/E ratio
| 2011/12 | 2014/12 | 2015/12 | 2016/12 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | |
| Revenue | 6,963 | 773 | 742 | - | - | - | 178,146 | 171,169 | 2 | 3 |
| Revenue growth (%) | - | - | - | - | - | - | ||||
| Cost of revenue | 2,138 | - | - | - | - | - | 275,895 | 241,963 | 1 | 2 |
| Gross profit | 4,825 | - | - | - | - | - | -97,749 | -70,794 | 456,517 | 1 |
| Gross margin (%) | - | - | - | - | - | |||||
| Research & development | - | - | - | - | 2 | 2 | 4 | 5 | 7 | 5 |
| Selling, general & administrative | - | - | - | - | - | - | - | 7 | 7 | 8 |
| Operating margin (%) | - | - | - | - | ||||||
| Operating income | - | -35,914 | -48,845 | -32,611 | -5,813,394 | -4,902,261 | -10,218,211 | -10,030,765 | -11,955,250 | -11,887,209 |
| Operating expenses | 41,076 | 36,687 | 49,587 | 32,611 | 6 | 7 | 10 | 12 | 14 | 13 |
| Income before tax | - | -36,244 | -62,863 | -32,611 | - | - | - | - | -11,859,491 | -12,318,110 |
| Pretax margin (%) | - | -4,688.7 | -8,472.1 | - | - | - | - | - | -607.4 | -356.7 |
| Provision for income taxes | - | - | - | - | - | - | -271,122 | - | - | - |
| Effective tax rate (%) | - | - | - | - | - | - | - | - | - | - |
| Net income | -27,604 | -36,244 | -62,863 | -47,775 | -6,781,161 | -13,640,160 | -9,948,168 | -9,999,613 | -11,859,491 | -12,318,110 |
| Net income margin (%) | - | - | - | |||||||
| Earnings per share | - | - | - | - | - | - | - | -0.63 | -0.65 | -0.46 |
| Diluted EPS | - | - | - | - | - | - | - | -0.63 | -0.65 | -0.46 |
| EBITDA | - | - | - | - | - | - | ||||
| EBITDA margin (%) | - | - | - | - | - | - | - |